1. A phase 3, open‐label study of daclatasvir plus asunaprevir in Asian patients with chronic hepatitis C virus genotype 1b infection who are ineligible for or intolerant to interferon alfa therapies with or without ribavirin. Issue 11 (November 2016) Authors: Wei, Lai; Zhang, Mingxiang; Xu, Min; Chuang, Wan‐Long; Lu, Wei; Xie, Wen; Jia, Zhansheng; Gong, Guozhong; Li, Yueqi; Bae, Si Hyun; Yang, Yong‐Feng; Xie, Qing; Lin, Shumei; Chen, Xinyue; Niu, Junqi; Jia, Jidong; Garimella, Tushar; Torbeyns, Anne; McPhee, Fiona; Treitel, Michelle Journal: Journal of gastroenterology and hepatology Issue: Volume 31:Issue 11(2016:Nov.) Page Start: 1860 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the HALLMARK DUAL study. (28th April 2016) Authors: Kao, Jia‐Horng; Lee, Youn‐Jae; Heo, Jeong; Ahn, Sang‐Hoon; Lim, Young‐Suk; Peng, Cheng‐Yuan; Chang, Ting‐Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie Journal: Liver international Issue: Volume 36:Number 10(2016) Page Start: 1433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression. Issue 4 (August 2015) Authors: Bhagwagar, Zubin; Torbeyns, Anne; Hennicken, Delphine; Zheng, Ming; Dunlop, Boadie W.; Mathew, Sanjay J.; Khan, Arif; Weisler, Richard; Nelson, Craig; Shelton, Richard; Thase, Michael E.; Lane, Roger Journal: Journal of clinical psychopharmacology Issue: Volume 35:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression: Results From 2 Randomized, Double-Blind Studies. Issue 4 (August 2015) Authors: Bhagwagar, Zubin; Torbeyns, Anne; Hennicken, Delphine; Zheng, Ming; Dunlop, Boadie W.; Mathew, Sanjay J.; Khan, Arif; Weisler, Richard; Nelson, Craig; Shelton, Richard; Thase, Michael E.; Lane, Roger Journal: Journal of clinical psychopharmacology Issue: Volume 35:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical Trials. Issue 4 (29th May 2019) Authors: Simon, Teresa A.; Soule, Benjamin P.; Hochberg, Marc; Fleming, Douglas; Torbeyns, Anne; Banerjee, Subhashis; Boers, Maarten Journal: ACR open rheumatology Issue: Volume 1:Issue 4(2019) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Short‐duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study). (2nd February 2017) Authors: Sulkowski, Mark S.; Flamm, Steve; Kayali, Zeid; Lawitz, Eric J.; Kwo, Paul; McPhee, Fiona; Torbeyns, Anne; Hughes, Eric A.; Swenson, Eugene S.; Yin, Philip D.; Linaberry, Misti Journal: Liver international Issue: Volume 37:Number 6(2017) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗